Skip to main content
. 2011 Jan 21;15(1):R35. doi: 10.1186/cc9983

Figure 5.

Figure 5

Plasma glucagon. When compared to placebo glucagon-like peptide-1 (GLP-1) caused a reduction in glucagon concentration AUC (# P < 0.01) and strong trend to decreased glucagon concentrations at baseline, commencement of feeding and completion of study (P = 0.06, P = 0.06 and P = 0.11 respectively).